Clinical management of breast cancer in males: A report of four cases

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 102, Issue 1, 2002, Pages 67-73

  Heinig, Joerg ^a   Jackisch, Christian ^a   Rody, Achim ^a   Koch, Olaf ^b   Buechter, Dorothe ^a   Schneider, Hermann P G ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Paracelsus Klinik Osnabruck   (Germany)

Author keywords

BRCA 2; Male breast cancer; Outcome; Prognosis; Risk factors; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; ESTROGEN; GEMCITABINE; LETROZOLE; MILTEFOSINE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE REPORT; DISEASE ASSOCIATION; FAMILY; GENE MUTATION; GERMANY; HEREDITY; HUMAN; KLINEFELTER SYNDROME; LIVER CIRRHOSIS; MALE; MALE BREAST; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION EXPOSURE; RELATIVE; RISK FACTOR; TREATMENT OUTCOME;

EID: 0037051686     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00551-6     Document Type: Article

References (50)

1. Cancer statistics
2. Male breast cancer: a 13-year review of 89 patients
3. Carcinoma of the male breast
4. Carcinoma of the male breast in association with the Klinefelter syndrome
5. Klinefelter syndrome and cancer: a family study
6. XX male with breast cancer
7. Breast carcinoma in a 46XX true hermaphrodite
8. Male breast cancer: factors influencing prognosis
9. Germline BRCA-1 mutations in selected men with prostate cancer
10. Carcinoma of the male breast
11. Localized male breast carcinoma and family history
12. Carcinoma of the male breast
13. Mutation analysis of BRCA-1 and BRCA-2 in male breast cancer population
14. BRCA-2 germline mutations are frequent in male breast cancer patients without a family history of the disease
15. Carcinoma of the breast in men
16. Cancer of the male breast with prolonged survival
17. Carcinoma of the male breast: analysis of prognosis compared with matched female patients
18. Mutations in the p53 gene in male breast cancer
19. Das mammakarzinom des mannes: radiotherapie und bestrahlungsergebnisse
20. Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience
21. Cancer of the male breast: a review
22. Tamoxifen in the treatment of male breast cancer
23. Breast reconstruction in a male with a transverse rectus abdominis flap
24. Clinical features and therapeutic management of male breast cancer
25. Treatment of advanced male breast cancer
26. Hormonal treatment of disseminated male breast cancer
27. Adjuvant chemotherapy in males with cancer of the breast
28. Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide
29. Male breast cancer: results of the treatment and prognostic factors in 397 cases
30. The prognosis of breast cancer in males: a report of 355 cases
31. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review
32. Male breast cancer: pathological and immunohistochemical features
33. Overexpression of c-erb-B2 is an independent marker of resistance to endocrine therapy in advanced breast cancer
34. Breast cancer risk in relatives of male breast cancer patients
35. Immunochistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) versus subjective grading (IRS)
36. The St. Gallen's Consensus Conference: an assessment
37. Molecular markers in male breast carcinoma
38. Prognostic factors for carcinoma of the male breast
39. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome
40. C-erb and p53 overexpression as predictors of survival in patients with male breast cancer
41. Male breast cancer: clinicopathological features, immunocytochemical characteristics and prognosis
42. Angiogenesis, p53, and c-erb-B2 immunoreactivity and clinicopathological features in male breast cancer
43. Bcl-2 and P53 expression in node- negative breast carcinoma: a study with long term follow-up
44. P53 mutations and steroid receptor status in breast cancer. Clinicopathological correlation and prognostic assesment
45. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor
46. Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators
47. Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinoma
48. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma
49. Oncogenes and male breast carcinoma: c-erb-B2 and p53 coexpression predicts a poor survival